Pioglitazone preserves pancreatic β-cells in patients with type 2 diabetes and impaired glucose tolerance

被引：0
|
作者：
Hamdy, O
Soodini, G
Martens, J
Verheught, C
Steppel, J
Caballero, AE
Bennani, T
Horton, ES
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A146 / A146
页数：1
相关论文
共 50 条
  • [1] Pioglitazone Decreases Asymmetric Dimethylarginine Levels in Patients with Impaired Glucose Tolerance or Type 2 Diabetes
    Tahara, Nobuhiro
    Yamagishi, Sho-ichi
    Mizoguchi, Minori
    Tahara, Atsuko
    Imaizumi, Tsutomu
    [J]. REJUVENATION RESEARCH, 2013, 16 (05) : 344 - 351
  • [2] Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
    DeFronzo, Ralph A.
    Tripathy, Devjit
    Schwenke, Dawn C.
    Banerji, MaryAnn
    Bray, George A.
    Buchanan, Thomas A.
    Clement, Stephen C.
    Henry, Robert R.
    Hodis, Howard N.
    Kitabchi, Abbas E.
    Mack, Wendy J.
    Mudaliar, Sunder
    Ratner, Robert E.
    Williams, Ken
    Stentz, Frankie B.
    Musi, Nicolas
    Reaven, Peter D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (12): : 1104 - 1115
  • [3] Effects of Pioglitazone versus Glimepiride on Abdominal Fat Glucose Metabolism in Patients with Impaired Glucose Tolerance and/or Type 2 Diabetes Mellitus
    Kodama, Norihiro
    [J]. CIRCULATION, 2012, 126 (21)
  • [4] The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial
    Grey, Andrew
    Bolland, Mark
    Fenwick, Sheryl
    Horne, Anne
    Gamble, Greg
    Drury, Paul L.
    Reid, Ian R.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (02) : 255 - 262
  • [5] Type 2 diabetes and impaired glucose tolerance among cardiac patients
    Enquobahrie, Daniel A.
    Dolidze, Nino
    Chapidze, Guluara
    Vadachkoria, Surab
    Soh, Jason
    Fitzpatrick, Annette
    Williams, Michelle A.
    [J]. ACTA CARDIOLOGICA, 2007, 62 (05) : 439 - 444
  • [6] Effects of Pioglitazone on Visceral Fat Metabolic Activity in Impaired Glucose Tolerance or Type 2 Diabetes Mellitus
    Kodama, Norihiro
    Tahara, Nobuhiro
    Tahara, Atsuko
    Honda, Akihiro
    Nitta, Yoshikazu
    Mizoguchi, Minori
    Kaida, Hayato
    Ishibashi, Masatoshi
    Abe, Toshi
    Ikeda, Hisao
    Narula, Jagat
    Fukumoto, Yoshihiro
    Yamagishi, Sho-ichi
    Imaizumi, Tsutomu
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (11): : 4438 - 4445
  • [7] Characteristics of Korean type 2 diabetes mellitus and impaired glucose tolerance patients
    Son, HY
    [J]. DIABETES MELLITUS: RECENT ADVANCES FOR THE 21ST CENTURY, 2000, 1209 : 15 - 18
  • [8] PHARMACOLOGICAL STRATEGIES FOR PREVENTING TYPE 2 DIABETES IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE
    Smith-Marsh, D.
    [J]. DRUGS OF TODAY, 2013, 49 (08) : 499 - 507
  • [9] How Does Pioglitazone Prevent Progression of Impaired Glucose Tolerance to Diabetes?
    Genuth, Saul M.
    [J]. DIABETES, 2013, 62 (11) : 3663 - 3665
  • [10] Impaired glucose tolerance and progression to type 2 diabetes in youth
    Krakoff, J
    Hanson, R
    Touger, L
    Bennett, P
    Knowler, W
    [J]. DIABETES, 2003, 52 : A70 - A70
12345